Literature DB >> 20300748

A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis.

Mitchell Lawrence Jones1, Jorge G Ganopolsky, Alain Labbé, Satya Prakash.   

Abstract

Microbial and fungal infections are a significant consideration in the etiology of all wounds. Numerous antimicrobial and antifungal formulations have been developed with varying degrees of efficacy and stability. Here, we report a nitric oxide producing probiotic adhesive patch device and investigate its antimicrobial and antifungal efficacy in vitro. This probiotic patch utilizes the metabolic activity of immobilized lactic acid bacteria, glucose, and nitrite salts for the production of gaseous nitric oxide (gNO), which is used as an antimicrobial agent against bacterial and fungal pathogens. Results show that application of gNO-producing probiotic patches to cultures of E. coli, S. aureus, P. aeruginosa, MRSA, T. mentagrophytes, and T. rubrum resulted in complete cell death at between 4 and 8 h, and application to cultures of A. baumannii, resulted in fewer than ten colonies detected per milliliter at 6 h. These results demonstrate that a gNO-producing probiotic patch device containing bacteria, glucose, and nitrite salts can produce sufficient levels of gNO over a therapeutically relevant duration to kill common bacterial and fungal wound pathogens in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300748     DOI: 10.1007/s00253-010-2490-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  12 in total

1.  Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds.

Authors:  Mitchell Jones; Jorge G Ganopolsky; Alain Labbé; Mirko Gilardino; Christopher Wahl; Christopher Martoni; Satya Prakash
Journal:  Int Wound J       Date:  2012-01-06       Impact factor: 3.315

2.  Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses.

Authors:  David Schairer; Luis R Martinez; Karin Blecher; Jason Chouake; Parimala Nacharaju; Philip Gialanella; Joel M Friedman; Joshua D Nosanchuk; Adam Friedman
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

3.  Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing.

Authors:  Imran Sulemankhil; Jorge Gabriel Ganopolsky; Christopher Anthony Dieni; Andrei Florin Dan; Mitchell Lawrence Jones; Satya Prakash
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

4.  Persister formation in Escherichia coli can be inhibited by treatment with nitric oxide.

Authors:  Mehmet A Orman; Mark P Brynildsen
Journal:  Free Radic Biol Med       Date:  2016-02-02       Impact factor: 7.376

Review 5.  The potential of nitric oxide releasing therapies as antimicrobial agents.

Authors:  David O Schairer; Jason S Chouake; Joshua D Nosanchuk; Adam J Friedman
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 6.  Nitric oxide therapy for dermatologic disease.

Authors:  Brandon L Adler; Adam J Friedman
Journal:  Future Sci OA       Date:  2015-08-01

7.  Quantitative Modeling Extends the Antibacterial Activity of Nitric Oxide.

Authors:  Darshan M Sivaloganathan; Mark P Brynildsen
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

Review 8.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

Review 9.  Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature.

Authors:  Sabina Fijan; Anita Frauwallner; Tomaž Langerholc; Bojan Krebs; Jessica A Ter Haar Née Younes; Adolf Heschl; Dušanka Mičetić Turk; Irena Rogelj
Journal:  Biomed Res Int       Date:  2019-12-12       Impact factor: 3.411

Review 10.  Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections.

Authors:  Allison J Kutner; Adam J Friedman
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.